A GROUNDBREAKING preclinical study has demonstrated that a chemotherapy-free, non-myeloablative conditioning regimen can induce durable mixed haematopoietic chimerism, restore immune tolerance, and completely reverse autoimmune type 1…

A GROUNDBREAKING preclinical study has demonstrated that a chemotherapy-free, non-myeloablative conditioning regimen can induce durable mixed haematopoietic chimerism, restore immune tolerance, and completely reverse autoimmune type 1…